Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Regenxbio (RGNX) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Regenxbio (RGNX) over the last 10 years, with Q3 2025 value amounting to $51.7 million.

  • Regenxbio's Shares Outstanding (Diluted Average) rose 175.0% to $51.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.7 million, marking a year-over-year increase of 175.0%. This contributed to the annual value of $49.5 million for FY2024, which is 1320.48% up from last year.
  • Latest data reveals that Regenxbio reported Shares Outstanding (Diluted Average) of $51.7 million as of Q3 2025, which was up 175.0% from $51.5 million recorded in Q2 2025.
  • Regenxbio's Shares Outstanding (Diluted Average)'s 5-year high stood at $51.7 million during Q3 2025, with a 5-year trough of $42510.0 in Q2 2021.
  • For the 5-year period, Regenxbio's Shares Outstanding (Diluted Average) averaged around $34.1 million, with its median value being $43.8 million (2021).
  • Per our database at Business Quant, Regenxbio's Shares Outstanding (Diluted Average) plummeted by 9989.03% in 2021 and then surged by 10150458.72% in 2023.
  • Over the past 5 years, Regenxbio's Shares Outstanding (Diluted Average) (Quarter) stood at $43.9 million in 2021, then fell by 1.73% to $43.2 million in 2022, then grew by 1.35% to $43.7 million in 2023, then rose by 13.2% to $49.5 million in 2024, then grew by 4.4% to $51.7 million in 2025.
  • Its last three reported values are $51.7 million in Q3 2025, $51.5 million for Q2 2025, and $51.4 million during Q1 2025.